The management of osteoporosis in children

  1. Inicio
  2. »
  3. Sin categoría
  4. »
  5. The management of osteoporosis in children

Osteoporos Int. 2016 Jul;27(7):2147-79. doi: 10.1007/s00198-016-3515-9. Epub 2016 Apr 28. Review.

The scope of this article is to review the manifestations of and risk factors for primary and secondary osteoporosis in children, to discuss the definition of pediatric osteoporosis, and to summarize recommendations for monitoring and prevention of bone fragility. As well, this article reviews when a child is a candidate for osteoporosis therapy, which agents and doses should be prescribed, the duration of therapy, how the response to therapy is adjudicated, and the short- and long-term side effects. With this information, the bone health clinician will be poised to diagnose osteoporosis in children and to identify when children need osteoporosis therapy and the clinical outcomes that gauge efficacy and safety of treatment.

Autor: Ward LM, Konji VN, Ma J.
Patrocinadores de la web
Lilly
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter
Kyowa Kirin
Amgen
Meiji Pharma
Faes Farma